Optoacoustic imaging shows potential for noninvasive diagnostics for thyroid disorders

October 22, 2019

A combination of multispectral optoacoustic tomography (MSOT) and ultrasound has been used to noninvasively characterize a range of thyroid disorders, according to new research published in the October issue of The Journal of Nuclear Medicine. By providing a semiquantitative analysis of functional parameters and tissue characterization, the novel noninvasive imaging technique can provide novel biomarker information for initial evaluation and differential diagnosis of thyroid disorders.

Thyroid disorders, including autoimmune disease (Graves' disease) and thyroid nodules, are common worldwide. The American Thyroid Association estimates that 12 percent, or 20 million, Americans have some type of thyroid disorder.

"Currently, evaluation and risk stratification methods for thyroid disorders include hormone testing, high-resolution ultrasound, scintigraphy and invasive procedures--fine needle aspiration biopsy and thyroidectomy," said Wolfgang Roll, MD, physician at the Department of Nuclear Medicine/University Hospital Münster. "Imaging with MSOT, which detects ultrasonic waves generated by the expansion of tissue illuminated with ultrashort laser pulses, has proven valuable in vascular imaging, inflammatory bowel diseases and oncology. Our study set out to evaluate if hybrid MSOT/ultrasound imaging might provide new biomarkers to further assess risk patterns for individual thyroid nodules without the need for invasive procedures."

Eighteen patients were included in the study: three patients with Graves' disease, three healthy volunteers, nine patients with benign thyroid nodules and three patients with malignant thyroid modules. For the comparison of Graves' disease with healthy thyroid tissue, 14 thyroid lobes (six with Graves' disease and eight with healthy tissue) were imaged with MSOT/ultrasound. To compare thyroid nodules, a total of 16 nodules (13 benign and three malignant) were imaged with MSOT/ultrasound. All patients also underwent a routine clinical thyroid evaluation, following international guidelines.

MSOT images were reconstructed, and several functional biomarkers and tissue parameters were analyzed, including deoxygenated hemoglobin, oxygenated hemoglobin, total hemoglobin, saturation of hemoglobin, fat content and water content. Regions of interest were drawn on ultrasound images and transferred to the corresponding coregistered MSOT images. Statistical analyses were then performed.

MSOT/ultrasound imaging found significantly higher deoxygenated hemoglobin and total hemoglobin, as well as significantly lower fat content, in Graves' diseases lobes as compared with healthy controls. When comparing thyroid nodules with MSOT/ultrasound, malignant thyroid nodules showed significantly lower saturation of hemoglobin and lower fat content than benign nodules. The authors noted that hybrid MSOT/ultrasound was easily applicable to patients with thyroid diseases and sufficiently reproducible.

"Optoacoustic imaging is a new opportunity to employ optical imaging for deep tissue analyses with potential clinical applications in various benign and malignant disease," Roll stated. "Our study has shown that hybrid MSOT/ultrasound can assess changes in tissue composition in thyroid disorders by providing semiquantitative functional parameters noninvasively. With additional preclinical and clinical translational research, these technical developments can help to improve diagnostics and assessment of therapy response in the future."
-end-
This study was made available online in March 2019 ahead of final publication in print in October 2019.

The authors of "Multispectral Optoacoustic Tomography of Benign and Malignant Thyroid Disorders: A Pilot Study" include Wolfgang Roll, Department of Nuclear Medicine, University Hospital Münster, Münster, Germany; Niklas A. Markwardt, Angelos Karlas and Vasilis Ntziachristos, Institute of Biological and Medical Imaging, Helmholtz Zentrum München, München, Germany, and Chair of Biological Imaging and TranslaTUM, Technische Universität München, München, Germany; Max Masthoff and Anne Helfen, Institute of Clinical Radiology, University Hospital Münster, Münster, Germany; Jing Claussen, iThera Medical, Munich, Germany; Michel Eisenblätter, Institute of Clinical Radiology, University Hospital Münster, Münster, Germany, and Division of Imaging Sciences and Biomedical Engineering, King's College London, London, United Kingdom; Alexa Hasenbach and Sven Hermann, European Institute for Molecular Imaging, University of Münster, Münster, Germany; Moritz Wildgruber, Institute of Clinical Radiology, University Hospital Münster, Münster, Germany, and Cells in Motion (CiM) Cluster of Excellence, University of Münster, Münster, Germany; and Michael Schäfers, Department of Nuclear Medicine, University Hospital Münster, Münster, Germany, European Institute for Molecular Imaging, University of Münster, Münster, Germany, and Cells in Motion (CiM) Cluster of Excellence, University of Münster, Münster, Germany.

Please visit the SNMMI Media Center for more information about molecular imaging and precision medicine. To schedule an interview with the researchers, please contact Rebecca Maxey at (703) 652-6772 or rmaxey@snmmi.org. Current and past issues of The Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.

About The Journal of Nuclear Medicine

The Journal of Nuclear Medicine (JNM) is the world's leading nuclear medicine, molecular imaging and theranostics journal, accessed more than 9 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field.

JNM is published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging--precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit http://www.snmmi.org.

Society of Nuclear Medicine and Molecular Imaging

Related Hemoglobin Articles from Brightsurf:

Tibetan antelope thrive at high altitudes using a juvenile form of blood oxygen transport
Adult Tibetan antelope have overcome oxygen deprivation on the high-altitude Tibetan Plateau through an unusual adaptation in which they permanently express a form of hemoglobin (the iron-containing oxygen transport protein in red blood cells) that other members of the cattle family only express as juveniles or when under extreme oxygen deprivation.

New mobile health tool measures hemoglobin without drawing blood
Researchers have developed a way to use smartphone images of a person's eyelids to assess blood hemoglobin levels.

Researchers reveal origins of complex hemoglobin by resurrecting ancient proteins
Researchers trace the evolutionary origins of hemoglobin by resurrecting ancient proteins from more than 400 million years ago.

How malaria parasites become resistant to artemisinin antimalarial drugs
Malaria parasite mutations that inhibit the endocytoic appetite for a host's red blood cells may render them resistant to artemisinin, a widely used frontline antimalarial drug, according to a new study, which reveals a key molecular mechanism of drug resistance.

Protein in blood protects against neuronal damage after brain hemorrhage
Patients who survive a cerebral hemorrhage may suffer delayed severe brain damage caused by free hemoglobin, which comes from red blood cells and damages neurons.

Both low and high levels of hemoglobin linked to increased risk of dementia
Having either low or high levels of hemoglobin in your blood may be linked to an increased risk of developing dementia years later, according to a study published in the July 31, 2019, online issue of Neurology®, the medical journal of the American Academy of Neurology.

UH researcher reports the way sickle cells form may be key to stopping them
University of Houston chemist Vassiliy Lubchenko is reporting a new finding in Nature Communications on how sickle cells are formed, which may lead not only to stopping their formation, but to new avenues for making uniformly-sized nanoparticles for industry.

Athletes with sickle cell traits are at more risk to collapse: here's why
A genetic variation known to affect sickle cell disease might be the reason why some college football players experience adverse clinical outcomes during periods of extreme physical exertion and others do not.

Application of nanosized LiFePO4 modified electrode to electrochemical sensor & biosensor
The aim of this paper was to construct nanosized LFP modified electrodes, which could be applied as working electrode for rutin analysis and as an electrochemical biosensor for direct electrochemistry of Hemoglobin (Hb).

New portable blood analyzer could improve anemia detection worldwide
To reduce the burden of anemia, health officials need a better picture of the disease's global impact, an understanding made viable by a portable and affordable way to analyze blood.

Read More: Hemoglobin News and Hemoglobin Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.